Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec;13(1):162-167.
doi: 10.1080/19336950.2019.1615824.

Cannabinoid interactions with ion channels and receptors

Affiliations
Review

Cannabinoid interactions with ion channels and receptors

Abeline Rose Watkins. Channels (Austin). 2019 Dec.

Abstract

Cannabidiol (CBD), the non-psychoactive component of Cannabis sativa, acts on a diverse selection of membrane proteins with promising therapeutic potential in epilepsy and chronic pain. One such protein is the voltage-gated sodium channel (Nav). CBD shows a lack of specificity for sodium channels; however, the method of interaction is still unknown. In this review, we will outline the studies that report reproducible results of CBD and other cannabinoids changing membrane channel function, with particular interest on Nav. Nav are implicated in fatal forms of epilepsy and are also associated with chronic pain. This makes Nav potential targets for CBD interaction since it has been reported to reduce pain and seizures. One potential method of interaction that is of interest in this review is whether CBD affects channel function by altering lipid bilayer properties, independent of any possible direct interaction with membrane channels. CBD's ability to interact with its targets is a novel and important discovery. This discovery will not only prompt further research towards CBD's characterization, but also promotes the application of cannabinoids as potentially therapeutic compounds for diseases like epilepsy and pain.

Keywords: CBD; Cannabidiol; cannabinoids; ion channels; membrane fluidity; review.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Line drawing chemical structures of cannabidiol (CBD) and trans-Δ⁹-tetrahydrocannabinol (THC)

Similar articles

Cited by

References

    1. Serpell M, Ratcliffe S, Hovorka J, et al. A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment. Eur J Pain. 2014;18(7):999–1012. - PubMed
    1. Ware MA, Wang T, Shapiro S, et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. Can Med Assoc J. 2010;182(14):E694–E701. - PMC - PubMed
    1. Wilsey B, Marcotte T, Deutsch R, et al. Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain. 2013;14(2):136–148. - PMC - PubMed
    1. Casey SL, Atwal N, Vaughan CW.. Cannabis constituent synergy in a mouse neuropathic pain model. Pain. 2017;158(12):2452–2460. - PubMed
    1. Kaplan JS, Stella N, Catterall WA, et al. Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome. Proc Natl Acad Sci. 2017;114(42):11229–11234. - PMC - PubMed

Publication types

Grants and funding

This work was supported by the Agrima Botanicals under research contract.

LinkOut - more resources